PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

por Smeltzer, M., Bunn, P.A., Clark, R., Arndt, R., Pruett, C., Roy, U., Hirsch, F., Mitsudomi, T., Wakelee, H., Scagliotti, G.
Publicado 2021

Oral bisphosphonate use and lung cancer incidence among postmenopausal women

por Tao, M H, Chen, S, Freudenheim, J L, Cauley, J A, Johnson, K C, Mai, X, Sarto, G E, Wakelee, H, Boffetta, P, Wactawski-Wende, J
Publicado 2018

Genomic characterization of thymic epithelial tumors in a real-world dataset

por Kurokawa, K., Shukuya, T., Greenstein, R.A., Kaplan, B.G., Wakelee, H., Ross, J.S., Miura, K., Furuta, K., Kato, S., Suh, J., Sivakumar, S., Sokol, E.S., Carbone, D.P., Takahashi, K.
Publicado 2023

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell l...

por Chen, H, Modiano, M R, Neal, J W, Brahmer, J R, Rigas, J R, Jotte, R M, Leighl, N B, Riess, J W, Kuo, C J, Liu, L, Gao, B, DiCioccio, A T, Adjei, A A, Wakelee, H A
Publicado 2014

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours

por Diaz-Padilla, I, Siu, L L, San Pedro-Salcedo, M, Razak, A R A, Colevas, A D, Shepherd, F A, Leighl, N B, Neal, J W, Thibault, A, Liu, L, Lisano, J, Gao, B, Lawson, E B, Wakelee, H A
Publicado 2012

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

por Krug, A K, Enderle, D, Karlovich, C, Priewasser, T, Bentink, S, Spiel, A, Brinkmann, K, Emenegger, J, Grimm, D G, Castellanos-Rizaldos, E, Goldman, J W, Sequist, L V, Soria, J -C, Camidge, D R, Gadgeel, S M, Wakelee, H A, Raponi, M, Noerholm, M, Skog, J
Publicado 2018

LBA75 Defining COVID-19 outcomes in thoracic cancer patients: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion)

por Baena Espinar, J., Torri, V., Whisenant, J., Hirsch, F.R., Rogado, J., de Castro Carpeño, J., Halmos, B., Ceresoli, G.L., Rueda, A. Gomez, Tiseo, M., Felip, E., Tarruella, M. Majem, Monnet, I., Tapan, U., Wakelee, H., Huang, L-C., Garassino, M.C., Peters, S., Horn, L., Hellmann, M.
Publicado 2020

P09.18 COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT)

por Whisenant, J., Wong, S., Torri, V., Revuelta, J., Halmos, B., Ceresoli, G., Monnet, I., Popat, S., Arrieta, O., Azab, M., Dingemans, A., Spasic, J., Van Meerbeeck, J., Recondo, G., Reinmuth, N., Valter, A., Unk, M., Ghalehtaki, R., Steinfort, D., Chorostowska-Wynimko, J., Viola, L., Horn, L., Peters, S., Wakelee, H.A., Garassino, M.C., Tapan, U.
Publicado 2021

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

por Bonomi, P D, Gandara, D, Hirsch, F R, Kerr, K M, Obasaju, C, Paz-Ares, L, Bellomo, C, Bradley, J D, Bunn Jr, P A, Culligan, M, Jett, J R, Kim, E S, Langer, C J, Natale, R B, Novello, S, Pérol, M, Ramalingam, S S, Reck, M, Reynolds, C H, Smit, E F, Socinski, M A, Spigel, D R, Vansteenkiste, J F, Wakelee, H, Thatcher, N
Publicado 2018

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

por Mazieres, J., Drilon, A., Lusque, A., Mhanna, L., Cortot, A.B., Mezquita, L., Thai, A.A., Mascaux, C., Couraud, S., Veillon, R., Van den Heuvel, M., Neal, J., Peled, N., Früh, M., Ng, T.L., Gounant, V., Popat, S., Diebold, J., Sabari, J., Zhu, V.W., Rothschild, S.I., Bironzo, P., Martinez-Marti, A., Curioni-Fontecedro, A., Rosell, R., Lattuca-Truc, M., Wiesweg, M., Besse, B., Solomon, B., Barlesi, F., Schouten, R.D., Wakelee, H., Camidge, D.R., Zalcman, G., Novello, S., Ou, S.I., Milia, J., Gautschi, O.
Publicado 2019